supported by the National Basic Research Program of China(973 project,grant number:2014CB542902);Tianjin Hongrentang Pharmaceutical Co.,Ltd.,Tianjin,China(grant number:HX202016)。
Objective: This study aimed to explore the effects of Chinese patent medicine(CPM) in reducing the incidence of major adverse cardiovascular events(MACE) in patients with coronary heart disease(CHD) angina pectoris an...
This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China(No.2017YFC1309401).
Objective To determine the impact of smoking on disease-specific health care utilization and medical costs in patients with chronic non-communicable diseases(NCDs).Methods Participants were middle-aged and elderly adu...
This research was financially supported by the National Natural Science Foundation of China(Grant Nos.81971715 and 91739113 to JWT;81770241,81830013 and Distinguished Young Scholar Grant 81325001 to JSO);the International Cooperation project(2015DFA31070)from the Ministry of Science and Technology of China;the Guangdong Natural Science Fund Committee(Grant 2015A030312009);the Changjiang Scholars Program from the Ministry of Education of China,the Sun Yatsen University Clinical Research 5010 Program;the Program of National Key Clinical Specialties to JSO.
Atherosclerosis(AS)is the main pathological cause of coronary heart disease(CHD).Current clinical interventions including statin drugs can effectively reduce acute myocardial infarction and stroke to some extent,but r...
Supported by National Basic Research Program of China(973 Program,No.2014CB542901)
Background Phlegm and blood stasis syndrome(PBSS) is one of the main syndromes in coronary heart disease(CHD). Syndromes of Chinese medicine(CM) are lack of quantitative and easyimplementation diagnosis standards. To ...
Supported by National Basic Research Program of China(973 program,No.2015CB554404)
Objective: To investigate the relationship between inflammatory factors and two Chinese medicine(CM) syndrome types of qi stagnation and blood stasis(QSBS) and qi deficiency and blood stasis(QDBS) in patients w...
supported by a National 973 Project(No.2015CB554405)
The pathophysiological characteristics of Phlegm-stasis Cementation Syndrome in Coronary Heart Disease(CHD) has been summarized in this article. According to epidemiological investigations, phlegm-stasis cementation s...
This work was supported by the grants from the Ministry of Science and Technology of China (No. 2011CB910900 to B.L.) and theNational Natural Science Foundation of China (Nos. 31271377 and 31470802 to B.L.).
The tumor necrosis factor-α (TNF-α) and monocytic cells play a critical role in the development of ath- erosclerosis, which is the major cause of coronary heart disease (CHD). In this work, we investigated the e...
Supported by the National Key Technology Research and Development Program of the Ministry of Science and Technology of China(No.2001BAI10B02);Science and Technology Planning Project of Guangdong Province,China(No.2012A032500017)
Objective: To evaluate the efficacy and safety of a combination therapy using Chinese medicine (CM) Shenzhu Guanxin Recipe (参术冠心方, SGR) and standard Western medicine treatment (SWMT) in patients with angin...
supported by the National Basic Research Program of China(2010CB732605);the Department of Science and Technology of Shandong Province(Y2007C075,ZR2010HQ017,and 2008RKB060);the Health Department of Shandong Province(Shandong Provincial Outstanding Medical Academic Professional Program,1020 Program,and 2009HD011);an Independent Innovation Foundation of Shandong University(2010TS082);a grant from the Jinan Science and Technology Bureau(201102073)
The association of circulating levels of cystatin C(CysC)and risk of recurrent cardiovascular events in patients with preexisting coronary heart disease are uncertain.To qualitatively and quantitatively address this i...
Background Alteration in the protein composition of high-density lipoprotein (HDL) has been proposed as a mechanism for the development of coronary heart disease (CHD).In HDL,an increase in serum amyloid A protein...